We are live on ! Find out more
BCAB icon

BioAtla

80 hedge funds and large institutions have $30.4M invested in BioAtla in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more call options, than puts

Call options by funds: $78K | Put options by funds: $13K

0.14% less ownership

Funds ownership: 1.06%0.92% (-0.14%)

7% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 29

2% less funds holding

Funds holding: 8280 (-2)

43% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 28

65% less capital invested

Capital invested by funds: $87.2M → $30.4M (-$56.8M)

Holders
80
Holders Change
-2
Holders Change %
-2.44%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
27
Increased
16
Reduced
28
Closed
29
Calls
$78K
Puts
$13K
Net Calls
+$65K
Net Calls Change
-$424K

BCAB Hedge Fund Activity: Q2 2024 in Review

80 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2024, worth a combined $30.4M — down 65% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of BCAB and 27 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 16 added.

The largest buyer was Millennium Management, adding an estimated $1.85M. The largest seller was BlackRock, cutting an estimated $4.73M.

  • 80 institutional investors held BioAtla (BCAB) as of Q2 2024, down from 82 in Q1 2024.
  • Funds reported $30.4M of BioAtla stock for Q2 2024, down 65% quarter-over-quarter.
  • 27 funds opened new BioAtla positions in Q2 2024 and 29 closed out, a net change of -2 holders.
  • The largest BioAtla buyer in Q2 2024 was Millennium Management, an estimated $1.85M added.
  • The largest BioAtla seller in Q2 2024 was BlackRock, an estimated $4.73M sold.

Based on aggregated 13F filings for Q2 2024.